Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 4
Submit an article Journal homepage
898
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

MicorRNA-195 links long non-coding RNA SEMA3B antisense RNA 1 (head to head) and cyclin D1 to regulate the proliferation of glioblastoma cells

Kaijun Liua Department of Neurosurgery, Shiyan Taihe Hospital (Affiliated Taihe Hospital of Hubei University of Medicine), Shiyan City, PR. ChinaView further author information
,
Yan Denga Department of Neurosurgery, Shiyan Taihe Hospital (Affiliated Taihe Hospital of Hubei University of Medicine), Shiyan City, PR. ChinaView further author information
,
Yongxia Yangb Community Health Service Center of Shiyan Economic Development Zone, Shiyan City, PR. ChinaView further author information
,
Hui Wanga Department of Neurosurgery, Shiyan Taihe Hospital (Affiliated Taihe Hospital of Hubei University of Medicine), Shiyan City, PR. ChinaView further author information
&
Ping Zhoua Department of Neurosurgery, Shiyan Taihe Hospital (Affiliated Taihe Hospital of Hubei University of Medicine), Shiyan City, PR. ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9552-1102View further author information
ORCID Icon
Pages 8798-8805 | Received 21 Oct 2021, Accepted 09 Mar 2022, Published online: 31 Mar 2022

References

  • Rock K, McArdle O, Forde P, et al. A clinical review of treatment outcomes in glioblastoma multiforme—the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival? Br J Radiol. 2012;85(1017):e729–e733.
  • Aldape K, Zadeh G, Mansouri S, et al. Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015;129(6):829–848.
  • Delgado-Lopez PD, Corrales-Garcia EM. Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol. 2016;18(11):1062–1071.
  • Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.
  • Brandes AA, Vastola F, Basso U, et al. A prospective study on glioblastoma in the elderly. Cancer. 2003;97(3):657–662.
  • Li QJ, Cai JQ, Liu CY. Evolving molecular genetics of glioblastoma. Chin Med J (Engl). 2016;129(4):464–471.
  • Liu A, Hou C, Chen H, et al. Genetics and epigenetics of glioblastoma: applications and overall incidence of IDH1 mutation. Front Oncol. 2016;6:16.
  • Han L, Zhang K, Shi Z, et al. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol. 2012;40(6):2004–2012.
  • Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391–407.
  • Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Invest. 2016;126(8):2775–2782.
  • Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl). 2016;94(12):1313–1326.
  • Liu Y, Wang LL, Chen S, et al. LncRNA ABHD11‐AS1 promotes the development of endometrial carcinoma by targeting cyclin D1. J Cell Mol Med. 2018;22(8):3955–3964.
  • Hui W, Yuntao L, Lun L, et al. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PloS One. 2013;8(1):e54932.
  • Guo W, Liang X, Liu L, et al. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression. Gastric Cancer 2019 1–18 doi: 10.1007/s10120-018-0868-0
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25(4):402–408.
  • McNabb DS, Reed R, Marciniak RA. Dual luciferase assay system for rapid assessment of gene expression in Saccharomyces cerevisiae. Eukaryot Cell. 2005;4(9):1539–1549.
  • Muskhelishvili L, Latendresse JR, Kodell RL, et al. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67 (MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem. 2003;51(12):1681–1688.
  • Kato JY, Sherr CJ. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc Natl Acad Sci USA. 1993;90:11513–12115.
  • Shan YS, Hsu HP, Lai MD, et al. Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer. Oncol Lett. 2017;14(4):4517–4526.
  • Li X, Gong X, Chen J, et al. miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2. Biochem Biophys Res Commun. 2015;460(3):670–677.
  • Bhan A, Mandal SS. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim Biophys Acta. 2015;1856(1):151–164.
  • Qi P, Zhou X, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer. 2016;15(1):39.
  • Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing miRNA–lncRNA interactions(M)//Long Non-Coding RNAs. New York(NY): Humana Press; 2016. p. 271–286.
  • Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–282.
  • Wu Z. MiR-195 connects lncRNA RUNX1-IT1 and cyclin D1 to regulate the proliferation of glioblastoma cells. Int J Neurosci. 2021;1–6. doi:10.1080/00207454.2021.1881090
  • Wang J, Xia X, Tao X, et al. Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/β-catenin pathway. Bioengineered. 2021;12(1):3934–3946.
  • Liu L, Xiao S, Wang Y, et al. Identification of a novel circular RNA circZNF652/miR-486-5p/SERPINE1 signaling cascade that regulates cancer aggressiveness in glioblastoma (GBM). Bioengineered. 2022;13(1):1411–1423.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.